COVID-19：东京的抗体鸡尾酒疗法：在 120 家医疗机构进行管理
-小池知事宣布-
东京
知事小池百合子：
8月12日，
在东京的住宿设施
针对新型冠状病毒轻中度病例
明确启动“抗体鸡尾酒疗法”的政策。
抗体鸡尾酒疗法：
抗体鸡尾酒疗法仅限于医院使用。
东京都将通过在住宿设施配备医生来满足使用条件。
对新冠患者进行静脉滴注，防止病情加重。
在120家医疗机构管理：
允许120家医疗机构收治住院病人。
在东京都立公立医院
用于抗体鸡尾酒疗法的专用床，
他还展示了确保20张床位的想法。
日本经济新闻
https://www.nikkei.com/article/DGXZQOCC125RQ0S1A810C2000000/
Antibody cocktail therapy may cover more patients
Japan’s health ministry
is working to widen the scope of COVID-19 patients who can receive treatment using two newly approved drugs at the same time.
The ministry says
the treatment will be administered during short-term hospitalization.
In the so-called antibody cocktail treatment,
two drugs are given simultaneously to patients through intravenous drips to suppress the virus’s functions.
A clinical trial carried out overseas confirmed that the therapy reduced the risk of hospitalization or death by 70 percent.
The health ministry
will make arrangements together with local governments so that such patients will be able to receive the antibody cocktail treatment during short-term hospitalization.
The ministry hopes to expand the program as soon as possible.
NHK WORLD-JAPAN News
https://www3.nhk.or.jp/nhkworld/en/news/20210812_03/